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ABSTRACT 1 
Background: Binge eating and other forms of disordered eating behavior (DEB) are associated 2 
with failed inhibitory control. This study investigated the neural correlates of failed inhibitory 3 
control as a potential biomarker for DEB.  4 
Methods: The study used prospective longitudinal data from the European IMAGEN 5 
adolescent cohort. Participants completed baseline assessments (questionnaires and a brain 6 
scan [functional magnetic resonance imaging, fMRI]) at age 14, and a follow-up assessment 7 
(questionnaires) at 16. Self-reported binge eating and/or purging were used to indicate presence 8 
of DEB. Neural correlates of failed inhibition were assessed using the stop signal task. 9 
Participants were categorized as: Healthy Controls (reported no DEB at both time-points); 10 
Maintainers (reported DEB at both time-points); Recoverers (reported DEB at baseline only); 11 
and Developers (reported DEB at follow-up only). Forty-three individuals per group with 12 
complete scanning data were matched on gender, age, puberty and intelligence (N=172).  13 
Results: At baseline, despite similar task performance, incorrectly responding to stop signals 14 
(failed inhibitory control) was associated with greater recruitment of the medial prefrontal 15 
cortex and anterior cingulate cortex in the Developers compared to Healthy Controls and 16 
Recoverers.  17 
Conclusion: Greater recruitment of medial prefrontal and anterior cingulate regions during 18 
failed inhibition accords with abnormal evaluation of errors contributing to DEB 19 
development. As this precedes symptom onset, and is evident despite normal task 20 
performance, neural responses during failed inhibition may be a useful biomarker of 21 
vulnerability for DEB. This study highlights the potential value of prospective neuroimaging 22 
studies for identifying markers of illness before the emergence of behavior changes. 23 
 24 
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INTRODUCTION 1 
 2 
Eating disorders (EDs) are characterized by disturbed eating behaviors and extreme concerns 3 
about weight and shape. Onset usually occurs during adolescence (1), and early symptomatic 4 
behavior is predictive of later development of clinical disorders (2). It would be advantageous 5 
to be able to identify vulnerable individuals, however few prospective community-based 6 
studies have been conducted to investigate potential behavioral, biological or neural 7 
biomarkers of vulnerability. 8 
 9 
Adolescence is associated with more impulsive, risky and sensation-seeking behavior 10 
compared to childhood and adulthood, attributed at least partly to heterochronous regional 11 
brain development (3), e.g., between the maturity of subcortical regions associated with 12 
arousal, and immaturity of prefrontal and parietal regions integral to evaluative control over 13 
behavior (4). Such developmental events may lead to more impulsive behavior and confer 14 
risk of impulsive disordered eating behaviors (DEB). Indeed, neuroimaging studies of 15 
inhibitory control in adolescents with EDs have reported altered recruitment of frontostriatal 16 
networks implicated in reward processing and self-regulation, though the direction of effect is 17 
not consistent (5, 6). Thus, differences in neural functioning related to inhibitory control may 18 
contribute to the development of impulsive DEBs (7). It is unclear whether differences in 19 
neural activity associated with inhibitory control precede EDs, develop with the illness, or are 20 
a consequence of DEB. Prospective longitudinal neuroimaging are necessary to address these 21 
questions.  22 
 23 
Altered behavioral control has been implicated in ED pathology (8). Many symptoms revolve 24 
around the experience of control: e.g., a sense of loss of control during binge eating episodes, 25 
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and attempts to regain control over weight or food intake through food restriction/purging, 1 
while simultaneously experiencing the inability to stop engaging in restrictive or purging 2 
behaviors (9). These are transdiagnostic symptoms that are characteristic across ED 3 
diagnoses, with bulimia nervosa (BN) characterized by binge eating and purging, binge 4 
eating disorder (BED) by binge eating in the absence of compensatory purging, and the 5 
binge-purge subtype of anorexia nervosa (AN) involving binge eating and/or purging. 6 
Moreover, EDs (particularly BN and BED) are often comorbid with impulse control disorders 7 
(1, 10, 11) such as substance misuse disorders (12), and behavioral dys-control outside of 8 
eating contexts is common, suggesting self-regulatory difficulties occur across EDs (6). 9 
Additionally, a perceived loss of control (over behaviors, thoughts and/or environment) has 10 
been retrospectively identified by patients as contributing to the development of their ED (13-11 
16), and thus may constitute a risk factor for future ED development. 12 
 13 
This study used a large multi-national prospective neuroimaging dataset (17) to explore 14 
whether neural activity associated with motor inhibitory control can distinguish between 15 
individuals reporting DEBs at the time of a brain scan (age 14), those who develop these 16 
behaviors later (at age 16) and individuals who do not report/develop these behaviors. Such 17 
studies are difficult given the early onset of these disorders and the typical delay in 18 
presentation to the clinic. This pioneering project is the first to identify possible neural 19 
biomarkers of vulnerability to an ED. 20 
 21 
  22 
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METHODS AND MATERIALS 1 
 2 
Participants 3 
Participants were selected from a large European cohort study (the IMAGEN study: 17). A 4 
total of 2225 fourteen year olds [T1] were recruited from secondary schools at 8 sites (UK, 5 
Ireland, Germany and France). 1607 completed a follow-up assessment at ~16 years old [T2]. 6 
Participants were excluded from the IMAGEN study if they had any MRI contraindications, 7 
neurological/neurodevelopmental disorders, nutritional/metabolic diseases, certain 8 
historical/current medical conditions (e.g., congenital heart defects), IQ<70, or receiving 9 
treatment for schizophrenia/bipolar disorder (see 17). Participants in the present study were 10 
further excluded if they did not complete the diet, weight and shape element of the 11 
Development and Wellbeing Assessment (DAWBA) interview at both time-points, did not 12 
provide complete demographic data, or had inadequate/incomplete structural and functional 13 
(SST) MRI data).   14 
 15 
Eligible participants were categorized into four groups according to self-reported binge eating 16 
and purging (DEB):  individuals reporting DEB at both time-points (“Maintainers”, n=83 [71 17 
girls]), individuals reporting DEB at T1 only (“Recoverers”, n=59 [49 girls]), individuals 18 
reporting DEB at T2 only (“Developers”, n=159, [122 girls]), and individuals reporting no 19 
DEB (“Healthy Controls” (HC), n=1265, [567 girls]). Due to differences in group sizes, 20 
participants in each category were matched at an individual level to control for potential 21 
confounders in neuroimaging analyses of adolescents: age, gender, pubertal stage and 22 
intelligence quotient (IQ) (matching procedure outlined in Supplement A). Thus, a total sample 23 
of 172 participants comprised of 43 individuals (40 girls) from each group was analyzed 24 
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(Supplement B). A description of the endorsed DEBs is provided in supplementary files D and 1 
E. 2 
 3 
Questionnaires 4 
Disordered eating behavior, anxiety and depression were assessed using the DAWBA, which 5 
assesses the presence and frequency of symptoms of several psychiatric disorders (18). The 6 
Dieting, Weight and Shape section of the youth version was used to assess DEB: a positive 7 
response for either binge eating (eating an objectively large amount of food with associated 8 
loss of control; questions 15 and 16) and/or purging (actively getting rid of ingested food by 9 
self-induced vomiting or pill use; questions 1c, 18f and 18g) were used to indicate the 10 
presence of DEB. Due to insufficient frequency data, only the self-reported presence/absence 11 
of DEB was assessed in this study. Probability band scores for anxiety and depression, 12 
calculated using information provided by the adolescent, their parent, and their teacher, were 13 
used to assess anxiety and depression. Pubertal stage was determined using self-reports on the 14 
Pubertal Developmental Scale (PDS; 19). The short form of the Wechsler Intelligence Scale 15 
for Children 4th Edition (WISC-IV; 20) was administered to estimate cognitive ability. 16 
Lifetime cigarette, alcohol or hash use (i.e., substances known to affect appetite) was 17 
assessed at baseline and follow-up using the European School Survey Project on Alcohol and 18 
Drugs questionnaire (ESPAD; 21). 19 
 20 
Body Mass Index (BMI) 21 
Height and weight were measured at both time-points to calculate BMI (kg/m2). Standardized 22 
BMI z-scores were calculated to provide age and sex-adjusted relative weight-for-height 23 
assessments (22). 24 
 25 
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Stop Signal Task 1 
Neural responses to successful and failed inhibitory control were assessed using an fMRI stop 2 
signal task (SST). This reactive response inhibition task assesses action cancellation (23), and 3 
involves two concurrent tasks: a choice reaction time task (“go trials”: 80%, 400 trials) where 4 
participants must indicate the direction (left/right) of a presented arrow (“target”, 1000ms 5 
stimulus duration) using a button-press response, and a stop task where participants must 6 
inhibit their motor response (“stop trials”: 20%, 87 trials) when an unpredictable stop signal 7 
(upwards arrow, shown for 100-300ms) is presented at a variable delay after target onset. Stop 8 
trials were infrequent to encourage rapid responding. The delay between the target and stop 9 
signal (stop signal delay; SSD) was dynamically adjusted in a stepwise manner (in 50ms 10 
increments/decrements, range: 0-900ms, initial delay: 150ms) to ensure participants’ stop 11 
accuracy converges at approximately 50% correct inhibition. The inter-trial interval was 12 
1800ms. Behavioral dependent variables from this task included the mean SSD, stop accuracy, 13 
mean reaction time on correct go trials (mean RT) and the stop signal reaction time (SSRT). 14 
SSRT reflects the latency of the stop process (24), calculated by subtracting mean SSD from 15 
mean RT (25). 16 
 17 
Procedure 18 
Neuroimaging and questionnaire data were obtained from adolescents at T1; follow-up 19 
questionnaires were completed online at T2. The DAWBA, PDS and ESPAD were completed 20 
on a computer. A researcher administered the WISC-IV, at both time-points.  21 
 22 
Ethical approval 23 
Procedures were approved by local ethics committees at each site. Written informed consent 24 
from the parents and written assent from the children were obtained prior to participation. 25 
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 1 
Data analysis 2 
Between-group differences in demographic data and SST measures were explored using one-3 
way ANOVAs. Significant group differences were further assessed using Bonferroni-4 
corrected post-hoc t-tests. Square-root transformations were effective in normalizing the 5 
positively-skewed mean RT, SSD and post-error slowing data, and reflected square-root 6 
transformations were effective in normalizing the negatively-skewed SSRT data. The go 7 
accuracy data distribution was strongly negatively-skewed. Non-normally distributed 8 
demographic and task-based (go accuracy) data were assessed using non-parametric Kruskal-9 
Wallis tests and Bonferroni-corrected post-hoc Mann-Whitney U tests. All tests were two-10 
tailed, with the significance level set at α=0.05. 11 
 12 
Structural and functional MRI data were acquired using 3 Tesla MRI scanners of different 13 
manufacturers (including General Electric, Siemens, Philips, Bruker). Details of the structural 14 
and functional neuroimaging procedures are provided in the supplementary files (supplement 15 
C). Image preprocessing was completed using SPM12 (http://www.fil.ion.ucl.ac.uk/spm). 16 
fMRI data processing included manual origin setting, slice-time correction, realignment and 17 
coregistration to the T1-weighted structural scan. A study-specific template was created for 18 
normalization using Diffeomorphic Anatomical Registration using Exponentiated Lie 19 
Algebra (DARTEL; 26). The resultant flow fields were used to normalize the coregistered 20 
data to MNI space (27). Normalized images were smoothed using an 8mm FWHM Gaussian 21 
Kernel.  22 
 23 
Subject-specific regressors were created using onsets corresponding to the presentation of the 24 
go target, and duration corresponded to the latency between onset and response. These were 25 
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convolved with the canonical hemodynamic response function to create explanatory variables 1 
for the following trials: successful stop (SS) trials, failed stop (FS) trials, successful go (SG) 2 
trials, missed trials, incorrect go trials and early stop trials (i.e., responding before the 3 
appearance of the stop signal). The high pass filter was set to 128Hz, and potential residual 4 
autocorrelation was controlled for using an autoregressive function (AR(1)). Scans were 5 
checked manually and excluded if there was visual evidence of excessive motion. 6 
 7 
First-level contrasts were generated for the following a priori comparisons: failed>successful 8 
inhibition (error with intention to stop: FS>SS), failed stop>successful go 9 
(erroneous/unwanted vs. wanted response: FS>SG), and successful stop>successful go 10 
(successful inhibition: SS>SG). These were taken forward to group-level random-effects 11 
analyses, specifically 3 one-way ANCOVAs exploring the main effect of group followed by 12 
post-hoc t-tests, and subsequent regression analyses to identify group-by-covariate 13 
interactions in the relationships between neural recruitment and behavioral performance 14 
measures (transformed SSRT and post-error slowing). Cumulative head motion (sum of 15 
volume-to-volume Euclidean distance) and study site (dummy variables) were included as 16 
nuisance regressors in the models to control for confounding effects of head movement and 17 
site. We explored group differences in neural recruitment and the relationship between neural 18 
and behavioral outcomes in three planned group comparisons: 19 
 20 
• HC vs. Developers: As neither of these groups reported DEBs at the time of the scan, 21 
differences between them in neural activity may be a potential marker of future vulnerability;  22 
• HC vs. Maintainers: This allowed comparison of a group who showed current and prolonged 23 
DEB with a healthy group; 24 
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• Recoverers vs. Maintainers: Both groups reported DEBs at the time of scan, thus differences 1 
in neural activity should permit comparison between individuals displaying transient 2 
symptoms from individuals with more prolonged symptoms. 3 
  4 
Only results which survive FWE correction at p<0.05 at a cluster height threshold of p 5 
<0.001 will be considered significant.  6 
 7 
RESULTS 8 
 9 
 One-way ANOVAs and Kruskal-Wallis tests confirmed no differences between groups in 10 
age (F(3,168)=1.396, p=0.246), puberty (χ2(3)=1.947, p=0.583) and IQ (Verbal: 11 
F(3,168)=0.926, p=0.430; Performance: F(3,168)=0.130, p=0.942) (Table 1). Chi-squared 12 
analyses revealed no differences between the groups in lifetime use of substances known to 13 
affect appetite (all χ2(3) ≤6.057, p≥0.109; Supplement F), except for lifetime hash use at 14 
follow-up (χ2(3) =9.521, p=0.023). No differences were observed in the proportion of 15 
individuals reporting binge eating and purging between Recoverers and Maintainers at 16 
baseline or between Developers and Maintainers at follow-up (all U≥731.0, z≥-1.938, 17 
p≥0.053) (Supplement D). 18 
 19 
Table 1 20 
 21 
Group differences in BMI were present at baseline (F(3,171)=5.013, p=0.002), driven by 22 
lower BMI z-scores in the Developers compared to the Recoverers (t(84)=-3.203, p=0.002) 23 
and Maintainers (t(84)=-3.311, p=0.001), which survived Bonferroni correction. This was not 24 
due to differences in endorsement of food restriction amongst Developers (77%) compared to 25 
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either Recoverers (79%) or Maintainers (86%) (χ2(2)=1.080, p=0.583) (Supplement E). BMI 1 
z-scores were also lower in HCs compared to Recoverers (t(84)=-2.092, p=0.039) and 2 
Maintainers (t(84)=-2.198, p=0.031), though these findings did not survive Bonferroni 3 
correction. A trend towards a difference in anxiety (χ2(3)=6.508, p=0.089) and depression (χ2 4 
(3)=7.297, p=0.063) was also seen at baseline, driven by greater anxiety in the Developers 5 
compared to HCs, (U=668.0, z=-2.536, p=0.011), and greater depression in the Maintainer 6 
group compared to the Developer group (U=651.0, z=-2.579, p=0.010). However, these did 7 
not survive Bonferroni correction. No other group comparisons were significant at an 8 
uncorrected level (all p>0.053).  9 
 10 
Stop signal task 11 
 12 
Stop accuracy tended to converge around 40% accuracy (range: 28.7%-62.1%). One-way 13 
ANOVAs did not reveal any differences in behavioral performance between groups (Table 14 
2). 15 
 16 
Table 2 17 
 18 
A trend towards a main effect of group was observed on the contrast comparing failed stops 19 
to successful stops (FS>SS) in the right anterior cingulate cortex (ACC)/medial prefrontal 20 
cortex (PFC) (Table 3, Supplement G). No main effect of group was observed on the 21 
contrasts comparing failed stops to successful go (FS>SG) or successful stop to successful go 22 
trials (SS>SG).  23 
 24 
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Table 3 1 
 2 
Group comparisons were further evaluated using post-hoc t-tests. The Developers showed 3 
significantly greater recruitment during FS>SS compared to HC in a cluster spanning the 4 
ACC bilaterally, and compared to Recoverers in three clusters: the caudate (bilaterally); the 5 
right inferior parietal lobe, middle and superior temporal gyrus; and the right superior and 6 
middle frontal gyrus (Figure 1, Table 4). No differences were observed between the 7 
Maintainers, Recoverers and HCs. 8 
 9 
Figure 1 10 
Table 4 11 
 12 
Relationship between behavioral and neural performance  13 
 14 
When exploring the relationship between neural responses and adaptive error-related 15 
behavior (i.e., slowing responses after committing an error on the previous trial), a group by 16 
covariate interaction was found between post-error slowing and activation in two clusters 17 
during failed compared to successful stop trials (one in the precuneus (bilaterally), and 18 
another in the insula, thalamus and STG (bilaterally), left putamen and caudate). The 19 
parameter estimates (cluster means) were extracted and plotted for further inspection (Figure 20 
2). They revealed that during FS>SS, post-error slowing positively correlated with activity in 21 
the regions seen in HC and Developers, but negatively in Recoverers and Maintainers. 22 
 23 
Figure 2 24 
 25 
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DISCUSSION 1 
 2 
This study has prospectively identified potential neural correlates (biomarkers) associated 3 
with future onset of DEBs. It focused on inhibitory control, a core element of many models of 4 
ED (e.g., 7, 8, 28). When adolescents failed to inhibit their responses, those who developed 5 
binge eating/purging at age 16 showed greater recruitment of the anterior cingulate and 6 
medial PFC implicated in error processing and inhibitory control (29-32) than those who did 7 
not report these behaviors at age 16 (Recoverers and HC), suggesting that increased medial 8 
PFC activity during failed inhibitory control precedes symptom development. Thus, elevated 9 
recruitment of medial PFC and ACC during failed inhibitory control may be a biomarker for 10 
future DEB. Importantly, while behavioral performance did not differ, the observation that 11 
group by covariate interactions differed between the groups indicates that the relationship 12 
between behavior and neural response is disrupted. Thus, adolescents who later become 13 
symptomatic show intact inhibitory control at a behavioral level, but differ in the neural 14 
response to failed inhibitory control.  15 
 16 
It is surprising that there were no neural differences observed between HCs and Recoverers 17 
or Maintainers, given that the Recoverers and Maintainers were endorsing DEBs at the time 18 
of scanning. In this study, DEB was classified by self-report. As we did not have sufficient 19 
information regarding the frequency of the DEBs assessed, our DEB classification may span 20 
a range of symptom severities. It may be that the Recoverers engaged in DEB infrequently 21 
and therefore may be more similar to HCs with regards to their overall eating behavior, 22 
however this could not be formally assessed. Moreover, it is unknown if participants received 23 
treatment between the time-points, i.e., it cannot be ascertained whether “recovery” was 24 
spontaneous. Future replications could explore whether neural differences are associated with 25 
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differences in severity, and evaluate whether the absence of aberrant neural activity could be 1 
a marker of symptom cessation. 2 
 3 
An elevated medial PFC response in Developers may reflect differences in several 4 
processes/mechanisms during failed inhibition, e.g., less fully developed inhibitory 5 
processing (4, 30, 33, 34), poorer behavioral flexibility (33), enhanced error detection (31, 6 
35) or greater recruitment of attentional resources (36): the need to elucidate the role of these 7 
regions in behavioral responding has been highlighted (37). Group-by-covariate interactions 8 
assessed whether neural recruitment during failed inhibition was differentially associated 9 
with behavioral responding between the groups. In HCs, adaptive responding (greater post-10 
error slowing) was associated with greater recruitment of the thalamus, dorsal striatum and 11 
insula during failed inhibition. As the striatum has been implicated in reward processing and 12 
response selection (38) and the insula in self-regulation and emotional processing (39), this 13 
activation pattern may reflect the relationships between recruitment of evaluative (decision-14 
making) systems in response to failures and the subsequent deployment of an adaptive 15 
strategy (i.e., post-error slowing). While a similar relationship was observed in Developers 16 
with respect to post-error slowing, Maintainers and Recoverers displayed the opposite. 17 
Specifically, greater slowing following failure to inhibit was associated with less error-related 18 
recruitment in symptomatic individuals: post-error slowing (an adaptive behavioral response 19 
strategy) is negatively associated with error responses in individuals who reported DEB at the 20 
time of scan, and positively associated in those who were not symptomatic at the time of 21 
scan. As similar networks are implicated in risky and affective decision making (40-42) and 22 
decision making under uncertainty (43), our findings suggest that while enhanced neural 23 
responses to errors in the ACC/medial PFC may be a marker of risk for future DEB, the 24 
presence of DEBs is associated with abnormal processing of errors (i.e., there is a disconnect 25 
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between error-related brain activity and adaptive behavioral responding (post-error slowing) 1 
in symptomatic individuals), although no differences in the ability to respond adaptively was 2 
observed (44).  3 
 4 
Our data are consistent with models implicating frontostriatal systems in the 5 
development/maintenance of EDs (7, 45, 46). In addition, reduced recruitment of midline 6 
frontal regions has been reported in studies using the SST in individuals with ANR (47, 48). 7 
Importantly, while the directionality of the findings is inconsistent with our data, the same 8 
regions are being implicated. It is of note that all previous neuroimaging studies using the 9 
SST to assess EDs/DEBs have only assessed individuals with ANR and not those who binge 10 
eat/purge, and differed in the contrasts explored (hard/easy vs. failed/successful). Moreover, 11 
our study explored the relationship between inhibitory control and transdiagnostic symptoms 12 
of EDs, rather than its relationship with a particular ED diagnosis. Thus, the inherent sample-13 
based differences may contribute to the differences in directionality. However, rather than 14 
being viewed as opposing findings, this inconsistency may instead support spectrum models 15 
of EDs, which propose that EDs lie on a spectrum of inhibitory control with ANR at the over-16 
inhibited extremity and BN and BED at the impulsive extremity (8, 49). Our data, together 17 
with those of previous studies in ANR (47, 48), may therefore suggest that this spectrum of 18 
inhibitory control may be reflected at a neural level, with ANR associated with reduced 19 
recruitment and binge eating/purging associated with increased recruitment of the medial 20 
PFC and ACC during error-related processing compared to matched HCs. This may indicate 21 
reduced efficiency (greater recruitment for equivalent performance) within the error-22 
processing network in individuals who binge/purge compared to asymptomatic individuals. It 23 
may also be the over-engagement of frontal/cingulate regions in those who subsequently 24 
develop binge/purge behaviors. Alternatively, these findings could reflect enhanced 25 
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processing of errors as a function of augmented attentional processes, consistent with 1 
observations of greater sensitivity to rewards and punishment in individuals with EDs who 2 
binge and/or purge (50, 51). It would be of interest for future research to discriminate 3 
between these hypotheses.  4 
 5 
Similar regions have been implicated in studies of adolescents who binge/purge using other 6 
executive control tasks, though the directionality of findings has been inconsistent. Lock et 7 
al., (5) found that adolescents who reported binge eating and purging (including individuals 8 
with a diagnosis of either BN or ANBP) showed greater activity in frontal and midline 9 
regions during successful inhibition (compared to successful responding) in a task assessing 10 
action restraint (the go/no-go task) compared to HC. In contrast, Marsh et al., (6) found 11 
adolescents with BN had reduced neural recruitment of these regions during the Simon task. 12 
However, while all these tasks require a rapid button-press response, the Simon task required 13 
a response on all trials (i.e., had no stop/no-go trials) and compared reaction time on 14 
congruent and incongruent trials. Differences in directionality between these studies may 15 
therefore be due to differences in the type of inhibitory control assessed.  16 
  17 
There are some considerations regarding the method of participant categorization. Firstly, 18 
presence/absence of DEBs were determined by self-report. There is a debate surrounding the 19 
optimal method of assessing DEBs in children and adolescents, however, we found 20 
participants were forthcoming about their behaviors, with a greater prevalence of DEBs 21 
emerging from adolescent compared to parental reports (53). Secondly, participant groups 22 
were not random. However, the matching procedure is considered a strength of the study. 23 
Given the unequal sample sizes between the groups and the impact of pubertal stage, gender, 24 
age and IQ on neural development and neuropsychological performance, participants within 25 
19 
 
each group were matched at an individual level to reduce the possible influence of these 1 
variables while maintaining strong power. Thirdly, data were not collected on medication 2 
taken at the time of scan, which could affect inhibitory control (54, 55). Finally, this study is 3 
not able to determine the extent to which this potential neural biomarker is specific to the 4 
DEBs assessed, or a marker of ED vulnerability or impulsive behavior more generally. 5 
However, our findings accord with reports of altered error related brain activity (recruitment 6 
and coupling of the dorsal ACC following negative feedback on a probabilistic reversal 7 
learning task) in individuals with early stage AN compared to HC in the context of 8 
comparable behavioral performance (44). However, Geisler et al., (44) excluded participants 9 
who reported regular binge eating. Therefore, although our study differed from Geisler et al. 10 
(44) in terms of the fMRI task used and in terms of DEB studied, the findings from these 11 
studies suggest that altered error-related neural recruitment may precede observable 12 
differences in behavior, and may be a potential biomarker/endophenotype for ED 13 
vulnerability more generally. 14 
 15 
We propose that impulsivity-related recruitment of medial PFC and ACC is related to core 16 
symptoms of EDs and may indicate future development of binge eating and purging. Our 17 
findings have implications for biomarker research, as this neural profile predated symptom 18 
development, and while behavior could not discriminate the groups before symptom 19 
development, this was possible with neuroimaging. Thus, until better behavioral metrics are 20 
developed, neuroimaging may continue to be an important tool for identifying markers of 21 
psychopathological risk.   22 
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Table 1. Demographic information for the final matched sample of participants who responded at both 1 
time-points. 2 
Time-point  Measure Group [Mean (SD)] 
  HC Developers Recoverers Maintainers 
T1 (age 14 years)     
  Age (years) 14.61 (0.36) 14.49 (0.33) 14.66 (0.44) 14.57 (0.35) 
  BMI z-score 0.25 (1.04) 0.07 (0.88) 0.67 (0.82) 0.69 (0.83) 
  PDS 16.16 (1.46) 15.89 (2.10) 15.65 (2.94) 16.03 (2.17) 
  Verbal IQ 106.88 (13.35) 108.20 (11.24) 108.08 (14.57) 109.35 (13.16) 
  Performance IQ 104.53 (15.50) 104.80 (15.07) 105.42 (14.80) 106.44 (13.48) 
  Anxiety* 0.38 (0.66) 0.57 (0.98) 0.77 (1.07) 0.91 (1.31) 
  Depression* 0.50 (0.62) 0.46 (0.92) 0.88 (1.03) 0.97 (1.03) 
T2 (age 16 years)      
  Age (years) 16.46 (0.66) 16.47 (0.52) 16.51 (0.75) 16.60 (0.80) 
  BMI z-score -0.09 (1.10) 0.16 (1.06) 0.58 (1.00) 0.51 (0.99) 
* DAWBA probability band scores for an anxiety or depressive disorder.  3 
PDS=Puberty Development Scale. 4 
  5 
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Table 2. SST behavioral outcome data for the four groups, and statistical comparisons 1 
between-groups. 2 
  Group One-Way ANOVA 
Outcome  
(Mean (SD)) 
HC Developers Recoverers Maintainers   
Mean RT (ms) 475.99 
(83.75) 
477.10 
(96.19) 
456.66 
(73.02) 
465.87 
(81.09) 
F(3,167)=0.527, p=0.664 
Go Accuracy (%) 92.8% 
(8.9%) 
89.8% 
(12.9%) 
90.7% 
(15.1%) 
89.9% 
(11.5%) 
F(3,167)=0.548, p=0.650 
Stop Accuracy (%) 42.4% 
(5.4%) 
41.7% 
(6.0%) 
41.5% 
(4.9%) 
44.1% 
(5.2%) 
F(3,167)=0.673, p=0.570 
SSRT 227.47 
(101.60) 
227.07 
(75.85) 
242.37 
(64.32) 
241.73 
(108.71) 
F(3,167)=0.606, p=0.612 
Mean SSD 248.52 
(158.55) 
250.03 
(146.57) 
214.29 
(112.13) 
224.14 
(158.51) 
F(3,167)=2.077, p=0.105 
Post-error slowing 31.27 
(60.43) 
28.42 
(47.39) 
20.99 
(52.88) 
16.78 
(45.83) 
F(3,167)=0.606, p=0.612 
 3 
  4 
32 
 
Table 3. Peak coordinates emerging from the trend-wise main effect of group contrast on the one-way 1 
ANCOVA comparing neural recruitment between groups during failed relative to successful 2 
inhibition, covarying for total head motion and study site. 3 
 4 
Peak-
level 
p(FWE) 
 
F 
 
z k 
Coordinates of peak 
voxel (mm) Hemisphere Location of cluster peak(s) 
  
 
x y z 
  
0.094 9.72 4.36 122 20 42 10 Right Anterior Cingulate Cortex 
 5 
  6 
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Table 4. Peak coordinates of the significant clusters emerging from the post-hoc t-tests 1 
comparing neural recruitment between groups during failed relative to successful inhibition. 2 
A cluster (height) threshold of p<0.001 and cluster-wise family-wise error correction was applied 3 
(p(FWE)<0.05). 4 
 5 
 Cluster-
level 
p(FWE) 
k 
Coordinates of 
cluster peak(s) (mm) Hemisphere Location of cluster peak(s) 
 
 
x y z 
  
Developers > HC 
 
0.013 769 18 39 10 Right 
Frontal lobe/Anterior 
cingulate 
     12 33 15 Right Anterior cingulate 
     6 44 12 Right Anterior cingulate 
Developers > Recoverers 
 0.012 792 9 3 15 Right Caudate 
     0 -2 15   
     16 -4 14 Right Caudate (closest) 
 
0.015 744 48 -46 32 Right 
Supramarginal gyrus, 
parietal lobe 
     58 -57 22 Right Superior temporal gyrus 
     54 -64 26 Right  Middle temporal gyrus 
 
0.042 543 30 20 38 Right 
Frontal lobe (closest: middle 
frontal gyrus) 
     24 15 50 Right Middle frontal gyrus 
     24 26 57 Right Superior frontal gyrus 
 6 
 7 
  8 
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Figure 1. Statistical parametric maps resulting from post-hoc t-tests exploring regions that were more 1 
active during failed inhibition (compared to successful inhibition) in the Developers compared to HCs 2 
and the Recoverers (i.e., the groups who were asymptomatic at age 16). A cluster (height) threshold of 3 
p=0.001 and cluster-wise family-wise error correction was applied (p(FWE)<0.05). 4 
  5 
35 
 
Figure 2. Regression models assessing the relationship between fMRI parameter estimates and 1 
behavioral data. Graphs plotting the parameter estimates for each cluster emerging from the main 2 
effect of group analysis for each regression model, illustrating group differences in parameter 3 
estimates from clusters in which there was a relationship between post-error slowing and relative 4 
activity during failed stops compared to successful stops (row (A) = bilateral precuneus; row (B) = 5 
bilateral insula, STG and left thalamus, putamen and caudate). Three group comparisons were plotted 6 
(left to right: HC (blue) vs. Developers (orange); HC (blue) vs. Maintainers (green); Recoverers 7 
(purple) vs. Maintainers (green)). 8 
 9 
